Page last updated: 2024-10-21

4-aminopyridine and Hearing Loss

4-aminopyridine has been researched along with Hearing Loss in 2 studies

Hearing Loss: A general term for the complete or partial loss of the ability to hear from one or both ears.

Research Excerpts

ExcerptRelevanceReference
"Seizures were prevented in 50% and 75% of the animals by chronic CBZ and VPC, respectively."5.35Comparison of acute, chronic and post-treatment effects of carbamazepine and vinpocetine on hearing loss and seizures induced by 4-aminopyridine. ( Nekrassov, V; Sitges, M, 2008)
"Vinpocetine could be a promising alternative for the treatment of epilepsy."3.72Vinpocetine prevents 4-aminopyridine-induced changes in the EEG, the auditory brainstem responses and hearing. ( Nekrassov, V; Sitges, M, 2004)
"Seizures were prevented in 50% and 75% of the animals by chronic CBZ and VPC, respectively."1.35Comparison of acute, chronic and post-treatment effects of carbamazepine and vinpocetine on hearing loss and seizures induced by 4-aminopyridine. ( Nekrassov, V; Sitges, M, 2008)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nekrassov, V2
Sitges, M2

Other Studies

2 other studies available for 4-aminopyridine and Hearing Loss

ArticleYear
Comparison of acute, chronic and post-treatment effects of carbamazepine and vinpocetine on hearing loss and seizures induced by 4-aminopyridine.
    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2008, Volume: 119, Issue:11

    Topics: 4-Aminopyridine; Acoustic Stimulation; Animals; Anticonvulsants; Auditory Threshold; Carbamazepine;

2008
Vinpocetine prevents 4-aminopyridine-induced changes in the EEG, the auditory brainstem responses and hearing.
    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2004, Volume: 115, Issue:12

    Topics: 4-Aminopyridine; Animals; Drug Interactions; Electroencephalography; Epilepsy; Evoked Potentials, Au

2004